Condition
    Strong Evidence
    Effectiveness 4/5

    Iron for Lethargy

    Iron reliably improves lethargy where ferritin is low, and importantly it works even without anaemia. Where iron status is normal it does nothing and carries real risk — testing first is essential.

    Overview

    Lethargy — a heavy, effortful tiredness that is not relieved by rest — is one of the earliest symptoms of falling iron stores, and it responds to repletion well before any anaemia develops. In women with low ferritin and normal haemoglobin, randomised evidence shows a measurable reduction in fatigue on iron compared with placebo. The benefit is entirely conditional on being deficient. Where iron status is adequate, supplementation is inert at best and harmful at worst, which is why ferritin testing is the first step rather than an optional extra.

    Verdict

    Likely effective

    A randomised trial in non-anaemic women with low ferritin found significantly reduced fatigue on iron versus placebo. Benefit does not extend to people with normal iron stores.

    Unexplained deficiency needs investigating

    In men and postmenopausal women, iron deficiency is a red flag for gastrointestinal blood loss. Correcting the ferritin without finding the cause is not enough.

    How It Works

    Beyond haemoglobin, iron sits at the centre of oxidative phosphorylation as the metal in cytochromes and iron-sulfur clusters. When stores fall, mitochondrial ATP output declines in muscle and brain even while red cell mass is preserved, producing the subjective heaviness of lethargy without any change on a full blood count. Iron is also required for myoglobin in muscle and for neurotransmitter synthesis, so repletion tends to improve both physical endurance and mental sharpness together rather than one in isolation.

    Pathways involved

    Iron-sulfur clusters in the electron transport chain
    Cytochrome-dependent ATP production
    Myoglobin oxygen storage in muscle
    Dopamine and serotonin synthesis
    Haemoglobin oxygen delivery
    Hepcidin-controlled absorption

    Dosing & Protocol

    Trials in this population used roughly 40-100 mg of elemental iron daily, but current absorption physiology favours giving that dose on alternate days. Hepcidin rises for around 24 hours after a dose and suppresses uptake, so alternate-day regimens capture more of each tablet while halving gastrointestinal exposure. Vitamin C taken alongside improves absorption of non-haem iron. Tea, coffee, calcium, dairy and antacids all reduce it and should be kept two hours away from the dose.
    ScenarioDoseFormTiming
    Low ferritin, no anaemia40-100 mg elemental, alternate daysFerrous sulfateMorning with vitamin C
    Poor tolerance20-30 mg elemental, alternate daysFerrous bisglycinateWith a light meal
    On a proton pump inhibitor40-65 mg elemental, alternate daysFerrous sulfate plus ascorbic acidExpect slower repletion
    After repletionStop and retest-3 months after starting
    1. 1

      Measure ferritin with CRP· Before starting

      Inflammation inflates ferritin. Interpreting one without the other misses deficiency.

    2. 2

      Dose on alternate days with vitamin C· Weeks 1-12

      One tablet with a citrus source; skip the intervening day entirely.

    3. 3

      Track effort tolerance, not just mood· Ongoing

      Stair climbing, exercise recovery and afternoon slump are more reliable markers than a general sense of energy.

    4. 4

      Retest ferritin at three months· Month 3

      Stop when replete. If ferritin has not moved, absorption or ongoing loss needs review.

    Do not supplement blind

    Fatigue has many causes and iron overload is genuinely harmful. A ferritin result is the difference between a targeted intervention and an unnecessary risk.

    Evidence

    The key trial is a randomised, placebo-controlled study in menstruating women who were fatigued, non-anaemic and had low ferritin. Iron supplementation produced a significantly greater reduction in fatigue scores than placebo over twelve weeks, establishing that the symptom responds before anaemia develops. Supporting systematic review evidence confirms improvements in iron status and haematological markers with supplementation in this group. What the literature does not support is iron for tiredness in people with normal ferritin, where trials show no separation from placebo.

    Linked evidence for this pairing.

    Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial

    Score: 8/10
    2012
    rct
    n=198

    Vaucher P, Druais PL, Waldvogel S +1 more

    Iron reduced fatigue by about 48% from baseline versus 29% with placebo in non-anaemic women with low ferritin.

    View source
    Best available evidence
    Randomised placebo-controlled trial in non-anaemic women with low ferritin
    Typical effect
    Significant reduction in fatigue score versus placebo
    Studied dose
    Approximately 80 mg elemental iron daily in the trial setting
    Time to effect
    4-12 weeks
    Certainty of evidence
    Moderate, restricted to low-ferritin populations

    Safety

    Constipation, nausea and dark stools affect a substantial minority and are the usual reason people abandon treatment; lower doses, alternate-day schedules and gentler salts largely solve this. The non-negotiable safety points are that iron must not be taken without testing, that unexplained deficiency requires investigation for bleeding, and that iron tablets are a leading cause of fatal poisoning in young children and must be stored locked away.

    Reported effects

    Constipation and nausea
    Dark stools
    Iron overload if ferritin is normal
    Paediatric poisoning risk
    Masks the cause of GI blood loss if untested
    Multiple drug interactions

    Interactions & Conflicts

    Iron chelates several drug classes in the gut lumen and its own absorption is blunted by acid suppression and by common drinks. Almost all of this is manageable by separating doses in time rather than avoiding the medication.
    Interacts withSeverityMechanismAction

    References

    1. DOI: 10.1503/cmaj.110950

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.